Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177670 · ClinicalTrials.gov registry record
Adiana Post-Approval Clinical Study (APACS)
A clinical trial, sponsored by Hologic.
- Terminated
- Registry status
- 169
- Enrollment target
NCT01177670 is a clinical trial that was terminated before completion, run by Hologic. The registered enrollment target is 169 participants.
The verdict
NCT01177670 was terminated before completion, sponsored by Hologic.
- TERMINATED
- Registry status
- 169 participants
- Enrollment target
Study Summary
The Adiana Post-Approval Clinical Study (APACS) has been designed to compile information on the efficacy and safety of the Adiana Permanent Contraception System in the post market setting. Specifically, data will be collected that is relevant to the evaluation of the safety and efficacy of the Adiana System for women who desire permanent birth control by occlusion of the fallopian tubes. This study is an observational study that is not intended to test specific hypotheses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01177670
The ClinicalTrials.gov registry entry for NCT01177670 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01177670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01177670 about?
NCT01177670 is a clinical study titled "Adiana Post-Approval Clinical Study (APACS)". The Adiana Post-Approval Clinical Study (APACS) has been designed to compile information on the efficacy and safety of the Adiana Permanent Contraception System in the post market setting. Specifically, data will be collected that is relevant to the evaluation of the safety and efficacy of the Adian...
What is the current status of trial NCT01177670?
This trial is currently terminated. The enrollment target is 169 participants. The study started on 2010-08. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01177670?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.